Published On: Sun, Sep 11th, 2016

Citigroup Inc. Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €98.00 Price Target

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €98.00 ($108.89) price target from Citigroup Inc. in a report released on Tuesday. The brokerage currently has a a “buy” rating on the stock.
A number of other brokerages also recently commented on FME. Morgan Stanley set a €92.00 ($102.22) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Tuesday, July 26th. Berenberg Bank set a €94.00 ($104.44) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Friday, July 22nd. Jefferies Group set a €81.00 ($90.00) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a research note on Friday, July 8th. Oddo Securities set a €90.00 ($100.00) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Thursday, June 30th. Finally, Goldman Sachs Group Inc. set a €94.00 ($104.44) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Tuesday, June 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the stock. Fresenius Medical Care AG & Co. (Pref) currently has an average rating of “Buy” and an average target price of €88.97 ($98.86).
Shares of Fresenius Medical Care AG & Co. (ETR:FME) traded down 1.14% during mid-day trading on Tuesday, hitting €78.97. The stock had a trading volume of 186 shares. The stock has a market cap of €24.14 billion and a P/E ratio of 21.89. The company’s 50 day moving average is €81.40 and its 200-day moving average is €77.89. Fresenius Medical Care AG & Co. has a 52-week low of €67.50 and a 52-week high of €85.52.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/10/citigroup-inc-analysts-give-fresenius-medical-care-ag-co-pref-fme-a-98-00-price-target.html

Fresenius Medical Care AG & Co. (Pref) Company Profile
Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>